Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
12/9/2025
Ascletis Reports Positive Phase II Results for Oral GLP-1 Agonist ASC3...
12/9/2025
Biokin Reports Strong Phase 2 Results for HER2-Targeted ADC T-Bren
12/8/2025
Pfizer Files for Approval of Zavegepant Nasal Spray in China
12/8/2025
CSPC's Semaglutide Injection Moves Forward — sNDA Accepted, Obesity I...
12/4/2025
Lynk Receives FDA IND Approval for Its Brain-Penetrant Allosteric TYK2...
12/1/2025
New ADC Shows Broad Antitumor Activity With Strong Bystander Effect
12/1/2025
Innovent's Pecondle Wins China Approval as First Homegrown IL-23p19 An...
11/28/2025
Gan & Lee Launches GRADUAL-3 Phase 3 Trial of Once-Monthly Bofanglutid...
11/28/2025
Zhongmou Reports Strong First-in-Human Results for Optogenetic Gene Th...
11/28/2025
BeOne Secures USFDA Priority Review for Sonrotoclax
11/27/2025
Novartis's Rhapsido Approved for Chronic Spontaneous Urticaria in Chin...
11/27/2025
Ascentage Pharma Publishes Phase Ib Data for Olverembatinib in GIST
11/27/2025
NMPA Approves AstraZeneca's Imfinzi for NSCLC in China
11/27/2025
Biontech to Present Phase 2 Data for Bispecific Antibody Pumitamig in ...
11/27/2025
CSPC's JMT206 Wins Green Light for First-in-Human Trials in China
11/27/2025
Sugemalimab Wins European Approval for Stage III NSCLC
11/25/2025
Kelun Reports Positive Phase 2 Results for Sac-TMT Combined with KEYTR...
11/25/2025
Luye Pharma Receives FDA IND Clearance for LY03017
11/25/2025
Huaota Reports Pivotal Phase 3 Success for HB0017
11/25/2025
Pfizer's Hympavzi (Marstacimab) Gains NMPA Approval in China
11/21/2025
CSPC Advances Nectin-4 ADC SYS6002 Into First Phase 3 Trial
11/21/2025
Lynk Reports Positive Phase II Results for Topical JAK Inhibitor
11/21/2025
Innovent Moves Toward China Filing After High-Dose Obesity Drug Delive...
11/20/2025
Innovent's Mazdutide Achieves Strong Phase 3 Results in Chinese Obesit...
11/19/2025
China Accelerates Animal Testing in Ambitious Biotech Push
11/18/2025
Roche's Subcutaneous PD-L1 Therapy Wins China Approval
11/18/2025
Sinovac Expands Flu Vaccine Use to Infants from 6 Months
11/18/2025
Qilu to Share First-in-Human Data of Trispecific Antibody QLS4131 at A...
11/18/2025
Akeso's First CNS Candidate Cleared for Alzheimer's Clinical Trials in...
11/18/2025
Henlius and Organon Score First Interchangeable Biosimilar to Perjeta
Page:
1
/
20
Total number of articles:
595
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit